These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Agglutination of Trypanosoma cruzi in infected cells treated with serum from chronically infected mice. Wendelken JL, Rowland EC. J Parasitol; 2009 Apr; 95(2):337-44. PubMed ID: 18922039 [Abstract] [Full Text] [Related]
3. Antiegressin acts late in the intracellular growth cycle of Trypanosoma cruzi to inhibit parasite egress. Moore-Lai D, Rowland EC. J Parasitol; 2004 Feb; 90(1):85-91. PubMed ID: 15040671 [Abstract] [Full Text] [Related]
4. Discovery and characterization of an antibody, anti-egressin, that is able to inhibit Trypanosoma cruzi egress in vitro. Moore-Lai D, Rowland E. J Parasitol; 2004 Jun; 90(3):524-30. PubMed ID: 15270096 [Abstract] [Full Text] [Related]
5. Inhibition of Trypanosoma cruzi egress from infected fibroblasts is mediated by CD4+ and mu+ immune cells. Rowland EC, Chen Z. J Parasitol; 2003 Aug; 89(4):733-7. PubMed ID: 14533683 [Abstract] [Full Text] [Related]
6. Apoptotic lymphocytes treated with IgG from Trypanosoma cruzi infection increase TNF-alpha secretion and reduce parasite replication in macrophages. Montalvão F, Almeida GM, Silva EM, Borges VM, Vasconcellos R, Takiya CM, Lopes MF, Nunes MP, DosReis GA. Eur J Immunol; 2010 Feb; 40(2):417-25. PubMed ID: 19950177 [Abstract] [Full Text] [Related]
12. IFN-gamma, but not nitric oxide or specific IgG, is essential for the in vivo control of low-virulence Sylvio X10/4 Trypanosoma cruzi parasites. Marinho CR, Nuñez-Apaza LN, Martins-Santos R, Bastos KR, Bombeiro AL, Bucci DZ, Sardinha LR, Lima MR, Alvarez JM. Scand J Immunol; 2007 Feb; 66(2-3):297-308. PubMed ID: 17635807 [Abstract] [Full Text] [Related]
13. Trypanosoma cruzi antigen-specific antibody response in immunized mice during acute and chronic infection. Mikhail KS, Rowland EC. J Parasitol; 1990 Oct; 76(5):690-7. PubMed ID: 2120413 [Abstract] [Full Text] [Related]
14. Infection characteristics of an Ecuadorian Trypanosoma cruzi strain with reduced virulence. Rowland E, Luo H, McCormick T. J Parasitol; 1995 Feb; 81(1):123-6. PubMed ID: 7876970 [Abstract] [Full Text] [Related]
16. Trypanosoma cruzi: detection of a surface antigen cross-reactive to human C-reactive protein. Melo Coutinho CM, Cavalcanti GH, Bonaldo MC, Mortensen RF, Araújo-Jorge TC. Exp Parasitol; 1998 Oct; 90(2):143-53. PubMed ID: 9769244 [Abstract] [Full Text] [Related]
17. Comparison between autoantibodies arising during Trypanosoma cruzi infection in mice and natural autoantibodies. Ternynck T, Bleux C, Gregoire J, Avrameas S, Kanellopoulos-Langevin C. J Immunol; 1990 Feb 15; 144(4):1504-11. PubMed ID: 2106000 [Abstract] [Full Text] [Related]
18. Antibodies against Trypanosoma cruzi alkaline antigens are elicited in sera from acute but not chronic human chagasic patients. Zúñiga E, Montes C, Barbieri G, Gruppi A. Clin Immunol; 1999 Oct 15; 93(1):81-9. PubMed ID: 10497014 [Abstract] [Full Text] [Related]